Compare MRK & T Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRK | T |
|---|---|---|
| Founded | 2000 | 1983 |
| Country | United States | United States |
| Employees | N/A | 133030 |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 281.2B | 175.5B |
| IPO Year | 1994 | N/A |
| Metric | MRK | T |
|---|---|---|
| Price | $120.76 | $22.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 20 |
| Target Price | ★ $125.59 | $30.55 |
| AVG Volume (30 Days) | 8.6M | ★ 43.4M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | 3.06% | ★ 4.31% |
| EPS Growth | ★ 8.01 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.61 | $4.34 |
| Revenue Next Year | $5.41 | $2.14 |
| P/E Ratio | ★ N/A | $9.14 |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $76.66 | $21.99 |
| 52 Week High | $125.14 | $29.79 |
| Indicator | MRK | T |
|---|---|---|
| Relative Strength Index (RSI) | 58.90 | 37.31 |
| Support Level | $112.96 | N/A |
| Resistance Level | $123.93 | $26.32 |
| Average True Range (ATR) | 2.97 | 0.61 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 77.21 | 20.05 |
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
The wireless business contributes nearly 70% of AT&T's revenue. The company is the third-largest US wireless carrier, connecting 74 million postpaid and 17 million prepaid phone customers. Fixed-line enterprise services, which account for about 14% of revenue, include internet access, private networking, security, voice, and wholesale network capacity. Residential services, about 11% of revenue, primarily consist of in-home broadband internet access, serving 15 million customers. AT&T also has a sizable presence in Mexico, with 25 million wireless customers, but this business only accounts for 3% of revenue. The company recently sold its 70% equity stake in satellite television provider DirecTV to its partner, private equity firm TPG.